GlassScriptPhysician profile
Candace L Camelon
NPI 1316193287
$1,001.05
in general payments reported to CMS, 2019-2025
21 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $61.54 · 2023: $123 · 2024: $191 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $227.77 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $115.98 | 2025 | Veozah |
| Bioventus LLC | $81.72 | 2021-2022 | |
| Pfizer INC. | $68.40 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $64.65 | 2023-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Horizon Therapeutics Plc | $64.12 | 2021 | |
| Abbvie INC. | $49.78 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $38.55 | 2023 | Farxiga |
| Edwards Lifesciences Corporation | $35.40 | 2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.79 | 2023-2024 | Jardiance |
| Depuy Synthes Sales INC. | $28.00 | 2021 | |
| Amgen INC. | $26.79 | 2025 | Krystexxa |
| Abbott Laboratories | $23.13 | 2025 | Freestyle Libre 3 |
| Organogenesis INC. | $22.75 | 2022 | |
| Vanda Pharmaceuticals INC. | $21.29 | 2023 | Hetlioz |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $19.21 | 2021 | |
| Lilly USA, LLC | $18.94 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $17.56 | 2024 | Shingrix, Pediarix |
| Medtronic, INC. | $16.44 | 2022 | |
| Seqirus USA INC | $14.94 | 2025 | Flucelvax, Fluad |
| Exact Sciences Corporation | $14.84 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Camelon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.